Skip to main content
. 2005 Oct 4;93(9):986–992. doi: 10.1038/sj.bjc.6602802

Table 2. Multivariate analysis of prognostic factors in the validation set with overall survival as an end point.

Variate Hazard ratio 95% confidence interval P-value
Tumour size      
 ⩽5 cm 1    
 >5 cm 0.54 0.19–1.51 0.2400
       
Histological type      
 Differentiated 1    
 Undifferentiated 1.97 0.78–4.97 0.1500
       
Serosal invasion      
 Negative 1    
 Positive 3.38 1.21–9.50 0.0210
       
Lymph node metastasis      
 Negative 1    
 Positive 0.78 0.37–1.65 0.5200
       
CEA mRNA status      
 Negative 1    
 Positive 1.79 1.13–2.85 0.0130

CEA=carcinoembryonic antigen.